NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality

Stupp R, et al.：Eur J Cancer. 2012 Sep;48（14）:2192-202. doi: 10.1016/j.ejca.2012.04.011.

Clinical Practice Experience With Novo TTF-100A™System for Glioblastoma: The PatientRegistry Dataset （PRiDe）

Mrugala MM, et al.: Semin Oncol. 2014 Oct;41 Suppl 6:S4-S13. doi: 10.1053/j.seminoncol.2014.09.010.

Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub-group analysis of Korean patients in the EF-14 phase 3 trial

Kim CY, et al.: J Neurooncol. 2020 Feb;146（3）:399-406. doi: 10.1007/s11060-019-03361-2.

Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial

Toms SA, et al.: J Neurooncol. 2019 Jan;141（2）:467-473. doi: 10.1007/s11060-018-03057-z.

Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma

Lacouture ME, et al.: Front Oncol. 2020 Jul 28;10:1045. doi: 10.3389/fonc.2020.01045. eCollection 2020.

Global post-marketing safety surveillance of Tumor Treating Fields（TTFields） in patients with high-grade glioma in clinical practice

Shi W, et al.: J Neurooncol. 2020 Jul;148（3）:489-500. doi: 10.1007/s11060-020-03540-6. Epub 2020 Jun 13.

Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial

Taphoorn MJB, et al.: JAMA Oncol. 2018 Apr 1;4（4）:495-504. doi: 10.1001/jamaoncol.2017.5082.

Efficacy and Safety of Tumor Treating Fields （TTFields） in Elderly Patients with Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial

Ram Z, et al.: Front Oncol. 2021 Sep 27;11:671972. doi: 10.3389/fonc.2021.671972. eCollection 2021.

Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma A Randomized Clinical Trial

Stupp R, et al.: JAMA. 2015 Dec 15;314（23）:2535-43. doi: 10.1001/jama.2015.16669.

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma；A Randomized Clinical Trial

Stupp R, et al.: JAMA. 2017 Dec 19;318（23）:2306-2316. doi: 10.1001/jama.2017.18718.